Register now! 13th Annual Sentinel Initiative Public Workshop Nov. 8-9 - Drug Information Update

The U.S. Food and Drug Administration, under cooperative agreement with the Robert J. Margolis, MD, Center for Health Policy at Duke University, is hosting the 13th annual Sentinel Initiative public workshop virtually on November 8 and 9, 2021.  

The annual workshop is a gathering of the Sentinel community where leading experts share recent developments and achievements within the Sentinel Initiative, and promote engagement and collaboration with patients, industry, and consumers.  

This year’s meeting will feature a keynote presentation by Dr. Patrizia Cavazzoni, the director of FDA’s Center for Drug Evaluation and Research. The virtual public workshop will highlight milestones and strategic initiatives underway to enhance and build a more robust Sentinel Initiative. Stakeholders will discuss opportunities to utilize Sentinel’s existing data, infrastructure, and technology.  

The Sentinel System is a national electronic system for medical product safety surveillance. Mandated by the FDA Amendments Act, the Sentinel Initiative established the system in collaboration with public, academic, and private entities, as a method to obtain access to disparate data sources and validate methods to establish a system to link and analyze safety data from multiple sources. Sentinel has the largest multisite distributed database in the world dedicated to medical product safety.  

 For more information on the annual Sentinel Initiative workshop please visit the FDA’s Sentinel Initiative – News and Events page.